Table of Contents
ISRN AIDS
Volume 2013 (2013), Article ID 954806, 10 pages
http://dx.doi.org/10.1155/2013/954806
Review Article

Innate Immune Evasion Strategies by Human Immunodeficiency Virus Type 1

Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, 130 Desoto Street, Pittsburgh, PA 15261, USA

Received 30 May 2013; Accepted 9 July 2013

Academic Editors: B. Joos, H. C. Mwandumba, and C. Petrovas

Copyright © 2013 Debjani Guha and Velpandi Ayyavoo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Chieux, D. Hober, W. Chehadeh, and P. Wattré, “Anti-viral proteins: from interferon α to its receptor,” Annales de Biologie Clinique, vol. 57, no. 3, pp. 283–290, 1999. View at Google Scholar · View at Scopus
  2. G. Hajishengallis, H. Sojar, R. J. Genco, and E. DeNardin, “Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors,” Immunological Investigations, vol. 33, no. 2, pp. 157–172, 2004. View at Google Scholar · View at Scopus
  3. V. Racaniello, “Innate immune defenses,” 2009, http://www.virology.ws/2009/06/03/innate-immune-defenses/.
  4. A. Takaoka, Z. Wang, M. K. Choi et al., “DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response,” Nature, vol. 448, no. 7152, pp. 501–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Akira, “TLR signaling,” Current Topics in Microbiology and Immunology, vol. 311, pp. 1–16, 2006. View at Google Scholar · View at Scopus
  6. T. Kawai and S. Akira, “Signaling to NF-κB by Toll-like receptors,” Trends in Molecular Medicine, vol. 13, no. 11, pp. 460–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Yoneyama, W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita, “Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300,” EMBO Journal, vol. 17, no. 4, pp. 1087–1095, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Pitha, “Innate antiviral response: role in HIV-I infection,” Viruses, vol. 3, no. 7, pp. 1179–1203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. de Vries, J. Haasnoot, J. van der Velden et al., “Increased virus replication in mammalian cells by blocking intracellular innate defense responses,” Gene Therapy, vol. 15, no. 7, pp. 545–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Lever and A. M. L. Lever, “Intracellular defenses against HIV, viral evasion and novel therapeutic approaches,” Journal of the Formosan Medical Association, vol. 110, no. 6, pp. 350–362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Malim and M. Emerman, “HIV-1 accessory proteins-ensuring viral survival in a hostile environment,” Cell Host and Microbe, vol. 3, no. 6, pp. 388–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Goto, S. J. Kennel, M. Abe et al., “A novel membrane antigen selectively expressed on terminally differentiated human B cells,” Blood, vol. 84, no. 6, pp. 1922–1930, 1994. View at Google Scholar · View at Scopus
  13. R. Serra-Moreno, B. Jia, M. Breed, X. Alvarez, and D. T. Evans, “Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic Nef-deleted SIV,” Cell Host and Microbe, vol. 9, no. 1, pp. 46–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. McMichael, P. Borrow, G. D. Tomaras, N. Goonetilleke, and B. F. Haynes, “The immune response during acute HIV-1 infection: clues for vaccine development,” Nature Reviews Immunology, vol. 10, no. 1, pp. 11–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nazli, O. Chan, W. N. Dobson-Belaire et al., “Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Brenchley and D. C. Douek, “The mucosal barrier and immune activation in HIV pathogenesis,” Current Opinion in HIV and AIDS, vol. 3, no. 3, pp. 356–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Kanwar, D. Favre, and J. M. McCune, “Th17 and regulatory T cells: implications for AIDS pathogenesis,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Horejsh, T. J. Ruckwardt, and C. D. Pauza, “CXCR4-dependent HIV-1 infection of differentiated epithelial cells,” Virus Research, vol. 90, no. 1-2, pp. 275–286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Agrati, G. D'Offizi, M.-L. Gougeon et al., “Innate gamma/delta T-cells during HIV infection: terra relatively incognita in novel vaccination strategies?” AIDS Reviews, vol. 13, no. 1, pp. 3–12, 2011. View at Google Scholar · View at Scopus
  20. C. A. Derdeyn, J. M. Decker, F. Bibollet-Ruche et al., “Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission,” Science, vol. 303, no. 5666, pp. 2019–2022, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. B. F. Keele, E. E. Giorgi, J. F. Salazar-Gonzalez et al., “Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 21, pp. 7552–7557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M.-R. Abrahams, J. A. Anderson, E. E. Giorgi et al., “Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,” Journal of Virology, vol. 83, no. 8, pp. 3556–3567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Salazar-Gonzalez, M. G. Salazar, B. F. Keele et al., “Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection,” Journal of Experimental Medicine, vol. 206, no. 6, pp. 1273–1289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Marschang, C. F. Ebenbichler, and M. P. Dierich, “HIV and complement: role of the complement system in HIV infection,” International Archives of Allergy and Immunology, vol. 103, no. 2, pp. 113–117, 1994. View at Google Scholar · View at Scopus
  25. C. Speth and M. P. Dierich, “Modulation of cell surface protein expression by infection with HIV-1,” Leukemia, vol. 13, supplement 1, pp. S99–S105, 1999. View at Google Scholar · View at Scopus
  26. H. Stoiber, I. Frank, M. Spruth et al., “Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?” Molecular Immunology, vol. 34, no. 12-13, pp. 855–863, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Horakova, O. Gasser, S. Sadallah et al., “Complement mediates the binding of HIV to erythrocytes,” Journal of Immunology, vol. 173, no. 6, pp. 4236–4241, 2004. View at Google Scholar · View at Scopus
  28. Z. Bánki, D. Wilflingseder, C. G. Ammann et al., “Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells,” Journal of Immunology, vol. 177, no. 5, pp. 3469–3476, 2006. View at Google Scholar · View at Scopus
  29. S. Döpper, D. Wilflingseder, W. M. Prodinger et al., “Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures,” European Journal of Immunology, vol. 33, no. 8, pp. 2098–2107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Speth, T. Schabetsberger, I. Mohsenipour et al., “Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons,” Journal of Virology, vol. 76, no. 7, pp. 3179–3188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Pinter, A. G. Siccardi, L. Lopalco, R. Longhi, and A. Clivio, “HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology,” AIDS Research and Human Retroviruses, vol. 11, no. 8, pp. 971–980, 1995. View at Google Scholar · View at Scopus
  32. H. Stoiber, C. Ebenbichler, R. Schneider, J. Janatova, and M. P. Dierich, “Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1,” AIDS, vol. 9, no. 1, pp. 19–26, 1995. View at Google Scholar · View at Scopus
  33. H. Stoiber, C. Pintér, A. G. Siccardi, A. Clivio, and M. P. Dierich, “Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55),” Journal of Experimental Medicine, vol. 183, no. 1, pp. 307–310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Schmitz, J. P. Zimmer, B. Kluxen et al., “Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1520–1526, 1995. View at Google Scholar · View at Scopus
  35. D. C. Douek, L. J. Picker, and R. A. Koup, “T cell dynamics in HIV-1 infection,” Annual Review of Immunology, vol. 21, pp. 265–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S. M. Wahl, T. Greenwell-Wild, and N. Vázquez, “HIV accomplices and adversaries in macrophage infection,” Journal of Leukocyte Biology, vol. 80, no. 5, pp. 973–983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Vieillard, J. L. Strominger, and P. Debré, “NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 10981–10986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. B. He, X. Qiao, P. J. Klasse et al., “HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors,” Journal of Immunology, vol. 176, no. 7, pp. 3931–3941, 2006. View at Google Scholar · View at Scopus
  39. M. Müller-Trutwin and A. Hosmalin, “Role for plasmacytoid dendritic cells in anti-HIV innate immunity,” Immunology and Cell Biology, vol. 83, no. 5, pp. 578–585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Van Der Vlist, A. M. G. Van Der Aar, S. I. Gringhuis, and T. B. H. Geijtenbeek, “Innate signaling in HIV-1 infection of dendritic cells,” Current Opinion in HIV and AIDS, vol. 6, no. 5, pp. 348–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Walsh, N. Bhardwaj, and R. T. Gandhil, “Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1,” Current HIV Research, vol. 1, no. 2, pp. 205–216, 2003. View at Google Scholar · View at Scopus
  42. A. R. Stacey, P. J. Norris, L. Qin et al., “Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections,” Journal of Virology, vol. 83, no. 8, pp. 3719–3733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Rychert, D. Strick, S. Bazner, J. Robinson, and E. Rosenberg, “Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines,” AIDS Research and Human Retroviruses, vol. 26, no. 10, pp. 1139–1145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Kedzierska and S. M. Crowe, “Cytokines and HIV-1: interactions and clinical implications,” Antiviral Chemistry and Chemotherapy, vol. 12, no. 3, pp. 133–150, 2001. View at Google Scholar · View at Scopus
  45. L. Fantuzzi, F. Belardelli, and S. Gessani, “Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis,” Journal of Leukocyte Biology, vol. 74, no. 5, pp. 719–725, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Albini, S. Ferrini, R. Benelli et al., “HIV-1 Tat protein mimicry of chemokines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13153–13158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Giovanna Quaranta, E. Tritarelli, L. Giordani, and M. Viora, “HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4(+) T cell activation,” Experimental Cell Research, vol. 275, no. 2, pp. 243–254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Guha, P. Nagilla, C. Redinger, A. Srinivasan et al., “Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells,” Journal of Neuroinflammation, vol. 9, article 138, 2012. View at Google Scholar
  49. J. K. Yamamoto, F. Barre-Sinoussi, and V. Bolton, “Human alpha- and beta-interferon but not gamma–suppress the in vitro replication of LAV, HTLV-III, and ARV-2,” Journal of Interferon Research, vol. 6, no. 2, pp. 143–152, 1986. View at Google Scholar · View at Scopus
  50. W. Chen and J. Royer William E., “Structural insights into interferon regulatory factor activation,” Cellular Signalling, vol. 22, no. 6, pp. 883–887, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Pitha, “Multiple effects of interferon on the replication of human immunodeficiency virus type 1,” Antiviral Research, vol. 24, no. 2-3, pp. 205–219, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Hou, X. Wang, L. Ye et al., “Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages,” Journal of Virology, vol. 83, no. 8, pp. 3834–3842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. D. Barr, J. R. Smiley, and F. D. Bushman, “The interferon response inhibits HIV particle production by induction of TRIM22,” PLoS Pathogens, vol. 4, no. 2, Article ID e1000007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Martinelli, C. Cicala, D. Van Ryk et al., “HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3396–3401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. L. A. Zaritsky, L. Gama, and J. E. Clements, “Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2,” Journal of Immunology, vol. 188, no. 8, pp. 3876–3885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. V. Cobos Jimenez, T. Booiman, S. W. de Taeye et al., “Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons,” Scientific Reports, vol. 2, article 763, 2012. View at Google Scholar
  57. N. Yan, A. D. Regalado-Magdos, B. Stiggelbout, M. A. Lee-Kirsch, and J. Lieberman, “The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1,” Nature Immunology, vol. 11, no. 11, pp. 1005–1013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Lepelley, S. Louis, M. Sourisseau et al., “Innate sensing of HIV-infected cells,” PLoS Pathogens, vol. 7, no. 2, Article ID e1001284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. T. B. H. Geijtenbeek, “Host DNase TREX1 hides HIV from DNA sensors,” Nature Immunology, vol. 11, no. 11, pp. 979–980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Clerzius, J.-F. Gélinas, and A. Gatignol, “Multiple levels of PKR inhibition during HIV-1 replication,” Reviews in Medical Virology, vol. 21, no. 1, pp. 42–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Park, M. V. Davies, J. O. Langland et al., “TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 4713–4717, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. T. P. Chendrimada, R. I. Gregory, E. Kumaraswamy et al., “TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing,” Nature, vol. 436, no. 7051, pp. 740–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Gatignol, S. Laine, and G. Clerzius, “Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?” Retrovirology, vol. 2, article 65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Endo-Munoz, T. Warby, D. Harrich, and N. A. J. McMillan, “Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription,” Virology Journal, vol. 2, article 17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. S. R. Brand, R. Kobayashi, and M. B. Mathews, “The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR,” Journal of Biological Chemistry, vol. 272, no. 13, pp. 8388–8395, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. J.-F. Fonteneau, M. Larsson, A.-S. Beignon et al., “Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells,” Journal of Virology, vol. 78, no. 10, pp. 5223–5232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. J. A. Martinson, A. Roman-Gonzalez, A. R. Tenorio et al., “Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands,” Cellular Immunology, vol. 250, no. 1-2, pp. 75–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. J. C. Tilton, M. M. Manion, M. R. Luskin et al., “Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro,” Journal of Virology, vol. 82, no. 8, pp. 3997–4006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Lehmann, M. Lafferty, A. Garzino-Demo et al., “Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients,” PloS ONE, vol. 5, no. 6, Article ID e11110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. J. E. Ho, S. G. Deeks, F. M. Hecht et al., “Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals,” AIDS, vol. 24, no. 12, pp. 1897–1905, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. J.-P. Herbeuval, A. Boasso, J.-C. Grivel et al., “TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells,” Blood, vol. 105, no. 6, pp. 2458–2464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Lichtner, C. Marañón, P.-O. Vidalain et al., “HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4+ T lymphocytes,” AIDS Research and Human Retroviruses, vol. 20, no. 2, pp. 175–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. A. W. Hardy, D. R. Graham, G. M. Shearer, and J.-P. Herbeuval, “HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 44, pp. 17453–17458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. N. J. Megjugorac, H. A. Young, S. B. Amrute, S. L. Olshalsky, and P. Fitzgerald-Bocarsly, “Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells,” Journal of Leukocyte Biology, vol. 75, no. 3, pp. 504–514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Penna, M. Vulcano, S. Sozzani, and L. Adorini, “Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells,” Human Immunology, vol. 63, no. 12, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Alter, N. Teigen, B. T. Davis et al., “Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection,” Blood, vol. 106, no. 10, pp. 3366–3369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Alter, T. J. Suscovich, M. Kleyman et al., “Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection,” AIDS, vol. 20, no. 11, pp. 1549–1551, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. M. L. LaBonte, P. F. McKay, and N. L. Letvin, “Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression,” European Journal of Immunology, vol. 36, no. 9, pp. 2424–2433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. U.-C. Meier, R. E. Owen, E. Taylor et al., “Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections,” Journal of Virology, vol. 79, no. 19, pp. 12365–12374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Mavilio, G. Lombardo, A. Kinter et al., “Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2339–2350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. A. De Maria, M. Fogli, P. Costa et al., “The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44),” European Journal of Immunology, vol. 33, no. 9, pp. 2410–2418, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. M. P. Martin, Y. Qi, X. Gao et al., “Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1,” Nature Genetics, vol. 39, no. 6, pp. 733–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Alter, M. P. Martin, N. Teigen et al., “Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 3027–3036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. M. T. M. Vossen, E. M. Westerhout, C. Söderberg-Nauclér, and E. J. H. J. Wiertz, “Viral immune evasion: a masterpiece of evolution,” Immunogenetics, vol. 54, no. 8, pp. 527–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Ahmad and R. Ahmad, “HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity,” Current HIV Research, vol. 1, no. 3, pp. 295–307, 2003. View at Google Scholar · View at Scopus
  86. K. L. Collins and D. Baltimore, “HIV's evasion of the cellular immune response,” Immunological Reviews, vol. 168, pp. 65–74, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. G. B. Cohen, R. T. Gandhi, D. M. Davis et al., “The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells,” Immunity, vol. 10, no. 6, pp. 661–671, 1999. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Swigut, A. J. Iafrate, J. Muench, F. Kirchhoff, and J. Skowronski, “Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression,” Journal of Virology, vol. 74, no. 12, pp. 5691–5701, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Nattermann, H. D. Nischalke, V. Hofmeister et al., “HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells,” Antiviral Therapy, vol. 10, no. 1, pp. 95–107, 2005. View at Google Scholar · View at Scopus
  90. M. R. Zocchi, A. Rubartelli, P. Morgavi, and A. Poggi, “HIV-1 tat inhibits human natural killer cell function by blocking L-type calcium channels,” Journal of Immunology, vol. 161, no. 6, pp. 2938–2943, 1998. View at Google Scholar · View at Scopus
  91. A. Poggi, R. Carosio, G. M. Spaggiari et al., “NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain,” Journal of Immunology, vol. 168, no. 1, pp. 95–101, 2002. View at Google Scholar · View at Scopus
  92. L. Azzoni, R. M. Rutstein, J. Chehimi, M. A. Farabaugh, A. Nowmos, and L. J. Montaner, “Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children,” Journal of Infectious Diseases, vol. 191, no. 9, pp. 1451–1459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Richard, S. Sindhu, T. N. Q. Pham, J.-P. Belzile, and É. A. Cohen, “HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing,” Blood, vol. 115, no. 7, pp. 1354–1363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Douaisi, S. Dussart, M. Courcoul, G. Bessou, R. Vigne, and E. Decroly, “HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles,” Biochemical and Biophysical Research Communications, vol. 321, no. 3, pp. 566–573, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Zennou, D. Perez-Caballero, H. Göttlinger, and P. D. Bieniasz, “APOBEC3G incorporation into human immunodeficiency virus type 1 particles,” Journal of Virology, vol. 78, no. 21, pp. 12058–12061, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. R. S. Harris, K. N. Bishop, A. M. Sheehy et al., “DNA deamination mediates innate immunity to retroviral infection,” Cell, vol. 113, no. 6, pp. 803–809, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono, “Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts,” Nature, vol. 424, no. 6944, pp. 99–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. E. N. C. Newman, R. K. Holmes, H. M. Craig et al., “Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity,” Current Biology, vol. 15, no. 2, pp. 166–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Marin, K. M. Rose, S. L. Kozak, and D. Kabat, “HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation,” Nature Medicine, vol. 9, no. 11, pp. 1398–1403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. X. Yu, Y. Yu, B. Liu et al., “Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex,” Science, vol. 302, no. 5647, pp. 1056–1060, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda, “Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway,” Journal of Biological Chemistry, vol. 279, no. 9, pp. 7792–7798, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. S. de Silva and L. Wu, “TRIM5 acts as more than a retroviral restriction factor,” Viruses, vol. 3, no. 7, pp. 1204–1209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. T. Pertel, S. Hausmann, D. Morger et al., “TRIM5 is an innate immune sensor for the retrovirus capsid lattice,” Nature, vol. 472, no. 7343, pp. 361–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Aiken and S. Joyce, “Immunology: TRIM5 does double duty,” Nature, vol. 472, no. 7343, pp. 305–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. B. D. Kuhl, R. D. Sloan, D. A. Donahue, T. Bar-Magen, C. Liang, and M. A. Wainberg, “Tetherin restricts direct cell-to-cell infection of HIV-1,” Retrovirology, vol. 7, article 115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. S. J. D. Neil, S. W. Eastman, N. Jouvenet, and P. D. Bieniasz, “HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane,” PLoS Pathogens, vol. 2, no. 5, article e39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Rong, J. Zhang, J. Lu et al., “The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu,” Journal of Virology, vol. 83, no. 15, pp. 7536–7546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Jia, R. Serra-Moreno, W. Neidermyer Jr. et al., “Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2,” PLoS Pathogens, vol. 5, no. 5, Article ID e1000429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. F. Zhang, S. J. Wilson, W. C. Landford et al., “Nef proteins from simian immunodeficiency viruses are tetherin antagonists,” Cell Host and Microbe, vol. 6, no. 1, pp. 54–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Triboulet, B. Mari, Y.-L. Lin et al., “Suppression of MicroRNA-silencing pathway by HIV-1 during virus replication,” Science, vol. 315, no. 5818, pp. 1579–1582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. K. W. Witwer, J. M. Sisk, L. Gama, and J. E. Clements, “MicroRNA regulation of IFN-β protein expression: rapid and sensitive modulation of the innate immune response,” Journal of Immunology, vol. 184, no. 5, pp. 2369–2376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Gupta, P. Nagilla, H.-S. Le et al., “Comparative expression profile of miRNA and mRNA In primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1),” PloS ONE, vol. 6, no. 7, Article ID e22730, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Sun, H. Li, X. Wu et al., “Interplay between HIV-1 infection and host microRNAs,” Nucleic Acids Research, vol. 40, no. 5, pp. 2181–2196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. J. M. Sisk, J. E. Clements, and K. W. Witwer, “miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction,” Viruses, vol. 4, no. 10, pp. 1844–1864, 2012. View at Google Scholar
  116. Y. Bennasser, S.-Y. Le, M. Benkirane, and K.-T. Jeang, “Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing,” Immunity, vol. 22, no. 5, pp. 607–619, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Narayanan, K. Kehn-Hall, C. Bailey, and F. Kashanchi, “Analysis of the roles of HIV-derived microRNAs,” Expert Opinion on Biological Therapy, vol. 11, no. 1, pp. 17–29, 2011. View at Publisher · View at Google Scholar · View at Scopus